Avidity Biosciences, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2022 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: Avidity Biosciences, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2022 to Q2 2024.
Avidity Biosciences, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$0	-$1.18M	-100%	Jun 30, 2024	10-Q	2024-08-09
Q1 2024	$1.58M			Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$1.11M	-$1.26M	-53.3%	Dec 31, 2023	10-Q	2024-08-09
Q2 2023	$1.18M			Jun 30, 2023	10-Q	2023-08-08
Q4 2022	$2.36M			Dec 31, 2022	10-K	2024-02-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.